{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T21:25:57Z","timestamp":1777325157756,"version":"3.51.4"},"reference-count":45,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,10,29]],"date-time":"2018-10-29T00:00:00Z","timestamp":1540771200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"DOI":"10.3389\/fgene.2018.00450","type":"journal-article","created":{"date-parts":[[2018,10,29]],"date-time":"2018-10-29T12:04:32Z","timestamp":1540814672000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":19,"title":["Methadone Dosage and Plasma Levels, SNPs of OPRM1 Gene and Age of First Drug Use Were Associated With Outcomes of Methadone Maintenance Treatment"],"prefix":"10.3389","volume":"9","author":[{"given":"Sufang","family":"Peng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haifeng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiang","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuxing","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shujun","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunying","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2018,10,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"99","DOI":"10.2147\/PGPM.S33351","article-title":"Mu opioid receptor (OPRM1) as a predictor of treatment outcome in opiate-dependent individuals of Arab descent","volume":"5","author":"Al-Eitan","year":"2012","journal-title":"Pharmgenomics Pers. Med"},{"key":"B2","author":"Bament","year":"2004","journal-title":"Treatment Outcomes at 12 Months Post Admission to Drug Treatment: The Third Report of the South Australian Component of the Australian Treatment Outcomes Study - Heroin."},{"key":"B3","doi-asserted-by":"publisher","first-page":"53","DOI":"10.2147\/PGPM.S29272","article-title":"ABCB1 haplotype and OPRM1 118A > G genotype interaction in methadone maintenance treatment pharmacogenetics","volume":"5","author":"Barratt","year":"2012","journal-title":"Pharmgenomics Pers. Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/ajad.12172","article-title":"The role of opioidergic genes in the treatment outcome of drug addiction pharmacotherapy: a systematic review","volume":"24","author":"Bauer","year":"2015","journal-title":"Am. J. Addict"},{"key":"B5","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.drugalcdep.2005.05.010","article-title":"Cycling in and out of treatment; participation in methadone treatment in NSW, 1990-2002","volume":"81","author":"Bell","year":"2006","journal-title":"Drug Alcohol Depend"},{"key":"B6","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1007\/BF02190738","article-title":"Methadone maintenance treatment: an update","volume":"245","author":"Bertschy","year":"1995","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci"},{"key":"B7","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S0376-8716(00)00148-4","article-title":"The relationship of psychiatric comorbidity to treatment outcomes in methadone maintained patients","volume":"61","author":"Cacciola","year":"2001","journal-title":"Drug Alcohol. Depend"},{"key":"B8","first-page":"211","article-title":"A 5 years follow-up study on treatment retention rate of 1057 community methadone maintenance treatment patients in China","volume":"16","author":"Cao","year":"2010","journal-title":"China AIDS Vener. Dis."},{"key":"B9","first-page":"1687","article-title":"Status of methadone dosage in Guangdong province and estimate","volume":"37","author":"Chen","year":"2010","journal-title":"Mod. Prevent. Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1016\/j.pnpbp.2008.07.009","article-title":"Association of dopamine and opioid receptor genetic polymorphisms with response to methadone maintenance treatment","volume":"32","author":"Crettol","year":"2008","journal-title":"Prog. Neuro Psychopharmacol. Biol. Psychiat"},{"key":"B11","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.clpt.2006.09.012","article-title":"ABCB1 and cytochrome P450 genotypes and phenotypes: Influence on methadone plasma levels and response to treatment","volume":"80","author":"Crettol","year":"2006","journal-title":"Clin. Pharmacol. Ther"},{"key":"B12","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.clpt.2005.08.011","article-title":"Methadone enantiomer plasma levels, CYP2B6, CYP2C19, and CYP2C9 genotypes, and response to treatment","volume":"78","author":"Crettol","year":"2005","journal-title":"Clin. Pharmacol. Ther"},{"key":"B13","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1111\/j.1471-4159.2009.06472.x","article-title":"Single-nucleotide polymorphism (A118G) in exon 1 of OPRM1 gene causes alteration in downstream signaling by mu-opioid receptor and may contribute to the genetic risk for addiction","volume":"112","author":"Deb","year":"2010","journal-title":"J. Neurochem"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.2165\/00003088-200241140-00003","article-title":"Interindividual variability of the clinical pharmacokinetics of methadone: implications for the treatment of opioid dependence","volume":"41","author":"Eap","year":"2002","journal-title":"Clin. Pharmacokinet"},{"key":"B15","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1001\/jama.280.22.1936","article-title":"National consensus development panel on Effective medical treatment of opiate addiction","volume":"280","year":"1998","journal-title":"JAMA"},{"key":"B16","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1097\/JCP.0b013e318192eb00","article-title":"Major depressive disorder and patient satisfaction in relation to methadone pharmacokinetics and pharmacodynamics in stabilized methadone maintenance patients","volume":"29","author":"Elkader","year":"2009","journal-title":"J. Clin. Psychopharmacol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.drugalcdep.2008.11.006","article-title":"Promoting abstinence from cocaine and heroin with a methadone dose increase and a novel contingency","volume":"101","author":"Epstein","year":"2009","journal-title":"Drug Alcohol. Depend"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.3760\/cma.j.issn.0376-2491.2010.21.008","article-title":"Prospective study of Han's acupoint nerve stimulator for preventing relapse of detoxified heroin addicts","volume":"90","author":"Fang","year":"2010","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"B19","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S0376-8716(01)00171-5","article-title":"Retention rate and illicit opioid use during methadone maintenance interventions: a meta-analysis","volume":"65","author":"Farr\u00e9","year":"2002","journal-title":"Drug Alcohol. Depend"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e19527","DOI":"10.1371\/journal.pone.0019527","article-title":"Contribution of cytochrome P450 and ABCB1 genetic variability on methadone pharmacokinetics, dose requirements, and response","volume":"6","author":"Fonseca","year":"2011","journal-title":"PLoS ONE"},{"key":"B21","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.biopsych.2015.01.003","article-title":"Cis-expression quantitative trait loci mapping reveals replicable associations with heroin addiction in OPRM1","volume":"78","author":"Hancock","year":"2015","journal-title":"Biol. Psychiatry"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.2217\/pgs.11.96","article-title":"Impact of genetic polymorphisms in ABCB1, CYP2B6, OPRM1, ANKK1 and DRD2 genes on methadone therapy in Han Chinese patients","volume":"12","author":"Hung","year":"2011","journal-title":"Pharmacogenomics"},{"key":"B23","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.rcp.2014.02.005","article-title":"Evaluation of the methadone maintenance program of the risaralda mental hospital","volume":"43","author":"Isaza","year":"2014","journal-title":"Rev. Colomb. Psiquiatr"},{"key":"B24","doi-asserted-by":"publisher","first-page":"3387","DOI":"10.1172\/JCI60390","article-title":"Opiate addiction and cocaine addiction: underlying molecular neurobiology and genetics","volume":"122","author":"Kreek","year":"2012","journal-title":"J. Clin. Invest"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1016\/j.clinbiochem.2005.09.009","article-title":"Free and bound enantiomers of methadone and its metabolite, EDDP in methadone maintenance treatment: relationship to dosage?","volume":"38","author":"Lehotay","year":"2005","journal-title":"Clin. Biochem"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1093\/hmg\/ddn122","article-title":"ABCB1 (MDR1) genetic variants are associated with methadone doses required for effective treatment of heroin dependence","volume":"17","author":"Levran","year":"2008","journal-title":"Hum. Mol. Genet"},{"key":"B27","doi-asserted-by":"publisher","first-page":"755","DOI":"10.2217\/pgs.13.58","article-title":"Association of genetic variation in pharmacodynamic factors with methadone dose required for effective treatment of opioid addiction","volume":"14","author":"Levran","year":"2013","journal-title":"Pharmacogenomics"},{"key":"B28","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/BF03256276","article-title":"Interindividual variability of methadone response","volume":"12","author":"Li","year":"2008","journal-title":"Mol. Diag. Ther"},{"key":"B29","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.clpt.2005.09.010","article-title":"Modulation of the central nervous effects of levomethadone by genetic polymorphisms potentially affecting its metabolism, distribution, and drug action","volume":"79","author":"L\u00f6tsch","year":"2006","journal-title":"Clin. Pharmacol. Ther"},{"key":"B30","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1002\/syn.20355","article-title":"Differential regional effects of methadone maintenance compared to heroin dependence on mu-opioid receptor desensitization in rat brain","volume":"61","author":"Martin","year":"2007","journal-title":"Synapse"},{"key":"B31","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1080\/02791072.1999.10471730","article-title":"Optimizing response to methadone maintenance treatment: use of higher-dose methadone","volume":"31","author":"Maxwell","year":"1999","journal-title":"J. Psychoact. Drugs"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1300\/J069v21n03_01","article-title":"Optimizing long-term response to methadone maintenance treatment: a 152-week follow-up using higher-dose methadone","volume":"21","author":"Maxwell","year":"2002","journal-title":"J. Addict. Dis"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1124\/pr.112.007138","article-title":"Mu opioids and their receptors: evolution of a concept","volume":"65","author":"Pasternak","year":"2013","journal-title":"Pharmacol. Rev"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1007\/s00702-013-1029-6","article-title":"The dopamine receptor D1 gene is associated with the length of interval between first heroin use and onset of dependence in Chinese Han heroin addicts","volume":"120","author":"Peng","year":"2013","journal-title":"J. Neural Transm"},{"key":"B35","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.drugalcdep.2006.12.018","article-title":"Association of CYP2D6 ultrarapid metabolizer genotype with deficient patient satisfaction regarding methadone maintenance treatment","volume":"89","author":"P\u00e9rez de los Cobos","year":"2007","journal-title":"Drug Alcohol Depend"},{"key":"B36","volume-title":"Principles of Addiction Medicine","author":"Ries","year":"2009"},{"key":"B37","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/sj.cr.7290272","article-title":"SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci","volume":"15","author":"Shi","year":"2005","journal-title":"Cell Res."},{"key":"B38","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1002\/ajmg.b.30105","article-title":"Novel exonic mu-opioid receptor gene (OPRM1) polymorphisms not associated with opioid dependence","author":"Smith","year":"2005","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet"},{"key":"B39","volume-title":"Methadone Maintenance: Some Treatment Programs are Not Effective; Greater Federal Oversights Needed","year":"1990"},{"key":"B40","first-page":"37","article-title":"Factors associated with retention in a community-based methadone treatment among drug users in Urumqi","volume":"28","author":"Wang","year":"2007","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"key":"B41","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.euroneuro.2012.02.002","article-title":"Genetic polymorphisms in the opioid receptor mu1 gene are associated with changes in libido and insomnia in methadone maintenance patients","volume":"22","author":"Wang","year":"2012","journal-title":"Eur. Neuropsycho Pharmacol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S0140-6736(98)05356-2","article-title":"Role of methadone treatment in opiod dependence","volume":"353","author":"Ward","year":"1999","journal-title":"Lancet"},{"key":"B43","doi-asserted-by":"publisher","first-page":"e19601","DOI":"10.5812\/hepatmon.19601","article-title":"Risk factors of hepatitis c virus infection in drug users from eleven methadone maintenance treatment clinics in Xi'an, China","volume":"14","author":"Xiaoli","year":"2014","journal-title":"Hepat Mon"},{"key":"B44","doi-asserted-by":"publisher","first-page":"e1005910","DOI":"10.1371\/journal.pgen.1005910","article-title":"Pharmacogenomic study on methadone maintenance treatment identifies SNP rs17180299 and multiple haplotypes on CYP2B6, SPON1, and GSG1L associated with plasma concentrations of methadone r- and s-enantiomers in heroin-dependent patients","volume":"12","author":"Yang","year":"2016","journal-title":"PLoS Genet"},{"key":"B45","first-page":"985","article-title":"Analysis of quality of life and its influencing factors of heroin dependent patients with methadone maintenance therapy in Dehong prefecture, Yunnan province","volume":"45","author":"Zhang","year":"2011","journal-title":"Zhonghua Yu Fang Yi Xue Za Zhi"}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fgene.2018.00450\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,29]],"date-time":"2018-10-29T12:04:36Z","timestamp":1540814676000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fgene.2018.00450\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,29]]},"references-count":45,"alternative-id":["10.3389\/fgene.2018.00450"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2018.00450","relation":{},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,29]]},"article-number":"450"}}